At the Consortium of Multiple Sclerosis Centers Annual Meeting, I learned about the Pediatric MS Alliance from Jill Blackburn. I met Dr. Miriam Franco and learned about the app that she's developed and you'll want to download. And I sat down with Dr. Rosalind Kalb and MS Activist Marques Jones to learn about MS Path 2 Care – a new set of educational modules designed to empower people living with MS to be active participants in their own care & treatment.
We're also talking about a study that demonstrates that treatment with Ocrevus may improve cognitive ability in MS patients who are at risk of disease progression. We'll discuss research that suggests that MS patients who are living with depression and fatigue are less likely to adhere to their disease-modifying therapy as prescribed by their neurologist. And I'll tell you how they lowered the cost of MS prescription medications in the U.K.
Study Indicates that Ocrevus Improves Cognitiion 2:21
Study Indicates that Depression & Fatigue May Affect MS Patient Adherence to Disease-Modifying Therapy 3:32
The U.K. Lowers the Cost of MS Prescription Drugs 7:59
Interview with Jill Blackburn, of the Pediatric MS Alliance 11:26
Interview with Dr. Miriam Franco about the Imagerywork app 18:35
Interview with Dr. Rosalind Kalb & Marques Jones about MS Path 2 Care 22:46
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com
RealTalk MS Episode 38
Guests: Dr. Rosalind Kalb, Marques Jones, Dr. Miriam Franco, Jill Blackburn
Hosted By: Jon Strum
Tags: MS, MultipleSclerosis, CMSC18RocksNashville, PediatricMS, MSActivist, MSWarrior, Ocrevus, Imagerywork, MSPath2Care, RealTalkMS